Earnings took center stage again with a disappointment from IBM (IBM) and a better-than-expected performance from Morgan Stanley (MS) dividing markets. The Dow fell for its second day in a row. Morgan Stanley gave rise to the financials sector after posting increases in its quarterly earnings and revenue. The New York-based firm joined Citigroup (C) , JPMorgan (JPM) and Bank of America (BAC) in reporting a solid first quarter. Crude oil prices held near the flatline after a weekly reading on inventories showed a decline, though not as steep as analysts anticipated. U.S. stockpiles shrank by 1 million barrels, more than half the drop a week earlier. Abbott Laboratories (ABT) was active after beating estimates on its top- and bottom-line. Sales grew nearly 30% in a year full of acquisitions and product launches.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.